| # | Drug | Count |
|---|---|---|
| 0 | MEPOLIZUMAB | 4 |
| 1 | PREDNISONE | 2 |
| 2 | AMOXICILLIN | 1 |
| 3 | DORAVIRINE | 1 |
| 4 | DUPILUMAB | 1 |
| 5 | ECULIZUMAB | 1 |
| 6 | ERGOCALCIFEROL | 1 |
| 7 | FLUCONAZOLE | 1 |
| 8 | FLUTICASONE PROPIONATE AND SALMETEROL | 1 |
| 9 | INFLIXIMAB-DYYB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE | 1 | 0.0013 |
| 1 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 2 | MEPOLIZUMAB | 4 | 0.0001 |
| 3 | ERGOCALCIFEROL | 1 | 0.0000 |
| 4 | ECULIZUMAB | 1 | 0.0000 |
| 5 | FLUCONAZOLE | 1 | 0.0000 |
| 6 | VALACYCLOVIR HYDROCHLORIDE | 1 | 0.0000 |
| 7 | AMOXICILLIN | 1 | 0.0000 |
| 8 | PREDNISONE | 2 | 0.0000 |
| 9 | LEVOTHYROXINE SODIUM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 3 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 4 | Corticosteroid [EPC] | 2 | 0.0000 |